RAPT Therapeutics, Inc. (RAPT) Debt-to-equity % [USD] 2021 - 2024

Historical data

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: RAPT Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from 2021 to 2024.
RAPT Therapeutics, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 15.3 %, a 47.1% increase year-over-year.

Debt-to-equity, Quarterly (% [USD])

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	15.3	+4.89	+47.1%	Mar 31, 2024
Q4 2023	13.8	+3.76	+37.4%	Dec 31, 2023
Q3 2023	11.6	+1.9	+19.7%	Sep 30, 2023
Q2 2023	10.6	+1.66	+18.7%	Jun 30, 2023
Q1 2023	10.4	+2.49	+31.6%	Mar 31, 2023
Q4 2022	10	+2.07	+26%	Dec 31, 2022
Q3 2022	9.66	+0.2	+2.12%	Sep 30, 2022
Q2 2022	8.89			Jun 30, 2022
Q1 2022	7.89			Mar 31, 2022
Q4 2021	7.98			Dec 31, 2021
Q3 2021	9.45			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.